Bruker EVP sells 2,000 shares after option exercise

Bruker Corp executive Mark Munch reported an option exercise and related share sale.

Rhea-AI Filing Summary

Bruker Corp executive Mark Munch reported an option exercise and related share sale. He exercised stock options to acquire 2,000 shares of Common Stock at $22.19 per share and on the same day sold 2,000 shares in an open‑market transaction at $54.76 per share.

The filing notes that the sales were made under a pre‑arranged Rule 10b5‑1 trading plan. Following these transactions, Munch directly holds 128,443 shares of Bruker Common Stock.

Insider Trade Summary

Exercise and Sale: 2,000 shares ($65K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Munch Mark

Role EXEC VP&PRES BRUKER NANO INC.

Sold 2,000 shs ($110K)

Approx. gross sale proceeds $110K

Approx. exercise cost $44K

Approx. pre-tax spread $65K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Purchase)	2,000	$0.00	$0.00
Exercise	Common Stock	2,000	$22.19	$44K
Sale	Common Stock	2,000	$54.76	$110K

Holdings After Transaction: Stock Option (Right to Purchase) — 6,000 contracts (Direct); Common Stock — 128,443 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
2. F2. The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests on the first, second, third and fourth anniversaries of the Original Grant Date.

Key Figures

Shares sold: 2,000 shares Sale price: $54.76 per share Options exercised: 2,000 shares +3 more

6 metrics

Shares sold 2,000 shares Common Stock open-market sale

Sale price $54.76 per share Price for 2,000 Common Stock shares sold

Options exercised 2,000 shares Stock option exercise into Common Stock

Option exercise price $22.19 per share Strike price of exercised stock options

Shares held after transactions 128,443 shares Direct Common Stock holdings post-transaction

Option expiration October 4, 2026 Expiration date of 2,000-share option grant

Key Terms

Rule 10b5-1 trading plan, Stock Option (Right to Purchase), derivative exercise/conversion, open-market sale

4 terms

Rule 10b5-1 trading plan regulatory

"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Stock Option (Right to Purchase) financial

"security_title: "Stock Option (Right to Purchase)" for a derivative transaction of 2,000 shares."

derivative exercise/conversion financial

"transaction_action: "derivative exercise/conversion" describing the option exercise transactions."

open-market sale financial

"transaction_action: "open-market sale" for the 2,000 shares of Common Stock sold."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bruker (BRKR) executive Mark Munch report in this Form 4?

Mark Munch reported exercising stock options for 2,000 Bruker shares and selling 2,000 shares in the open market. The transactions occurred on the same date and reflect routine equity compensation activity combined with a share sale.

How many Bruker (BRKR) shares did Mark Munch sell and at what price?

Mark Munch sold 2,000 shares of Bruker Common Stock at $54.76 per share. The transaction was reported as an open‑market sale and formed part of his broader equity compensation and trading activity on that date.

What options did Mark Munch exercise in this Bruker (BRKR) Form 4?

He exercised stock options covering 2,000 Bruker Common Stock shares at a $22.19 exercise price. These options were from a grant originally dated October 4, 2016, which vests in four equal annual installments from the original grant date.

How many Bruker (BRKR) shares does Mark Munch hold after these transactions?

After completing the option exercise and related sale, Mark Munch directly holds 128,443 shares of Bruker Common Stock. This post‑transaction holding reflects his remaining equity stake reported in the Form 4 following the same‑day activity.

Were Mark Munch’s Bruker (BRKR) share sales under a Rule 10b5-1 plan?

Yes. A footnote explains that the sales reported were effected under a Rule 10b5‑1 trading plan adopted by Mark Munch. Such plans pre‑schedule trades, making the timing more mechanical and less discretionary than ad‑hoc market transactions.

What is the expiration date of the Bruker (BRKR) stock options exercised by Mark Munch?

The stock options exercised by Mark Munch, covering 2,000 Bruker shares at $22.19 per share, have an expiration date of October 4, 2026. They were granted on October 4, 2016 with vesting over four annual anniversaries.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/16/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Munch Mark

(Last) (First) (Middle)

BRUKER CORPORATION

40 MANNING ROAD

(Street)

BILLERICA MASSACHUSETTS 01821

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BRUKER CORP [ BRKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EXEC VP&PRES BRUKER NANO INC.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/15/2026		M		2,000	A	$22.19	130,443	D
Common Stock	06/15/2026		S		2,000(1)	D	$54.76	128,443	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Purchase)	$22.19	06/15/2026		M			2,000	(2)	10/04/2026	Common Stock	2,000	$0	6,000	D

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

2. The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests on the first, second, third and fourth anniversaries of the Original Grant Date.

	/s/ Michael Simone, Attorney-in-Fact	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)